Form 4: Telesis Bio Inc. Executive Rob Cutler Reports Changes in Beneficial Ownership

Chief Legal Officer Rob Cutler reports acquisition of restricted stock units and stock options, as well as shares withheld for tax obligations.

Summary

• On June 22, 2023, Rob Cutler, Chief Legal Officer of Telesis Bio Inc., was granted 13,800 restricted stock units (RSUs) and stock options for 111,800 shares.
• The RSUs vest 25% annually starting March 1, 2024, through March 1, 2027, contingent on continued service.
• The stock options vest 25% on March 1, 2024, with the remaining shares vesting monthly thereafter.
• On March 1, 2024, 1,376 shares were withheld by Telesis Bio Inc. to cover tax obligations related to the vesting of RSUs at a price of $0.528.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it's a routine disclosure of stock transactions. The granting of equity can be seen as a positive sign of aligning management interests, but the tax withholding is a neutral event.

Positives

• The granting of RSUs and stock options to a key executive aligns their interests with the long-term success of the company.

Future Outlook

The vesting schedules for the RSUs and stock options are contingent upon the Reporting Person's continued service with the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be useful for investors assessing management's confidence in the company.

Stakeholder Impact

• Shareholders can monitor insider transactions to gauge management's confidence in the company's future prospects.

Key Dates

Keywords

beneficial ownership, Form 4, Telesis Bio Inc., Rob Cutler, stock options, RSUs, restricted stock units, insider trading